NASDAQ · Medical Distribution · USD
111, Inc. (YI) Stock Analysis
111, Inc. (YI) is a Medical Distribution stock listed on NASDAQ and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
YI Key Statistics
As of Sep 4, 2026Trading
- Open
- $3.21
- Previous Close
- $3.33
- Day's Range
- 3.21–3.47
- 52-Week Range
- 2.48–11.17
- Volume
- 10.80K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.65
Valuation
- Market Cap
- $30.48M
- P/E Ratio
- unprofitable
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 24.75
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −7.68
Financials (FY)
- Revenue (FY)
- $12.56B−12.81%
- Net Income (FY)
- −$66.39M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −0.75%
- Shares Outstanding
- 5.20M
- 1-Year Return
- −37.02%
Dividend and dates
- Avg Volume
- 16.63K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
YI Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +35.55% |
| 2025 | +312.90% |
| 2024 | −60.00% |
| 2023 | −48.68% |
| 2022 | −13.71% |
| 2021 | −49.64% |
| 2020 | +3.27% |
| 2019 | +9.61% |
| 2018 (partial year) | −55.51% |
As of September 4, 2026.
YI Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $12.56B | −$66.39M | −0.5% |
| 2024 | $14.40B | −$64.74M | −0.4% |
| 2023 | $14.95B | −$392.69M | −2.6% |
| 2022 | $13.52B | −$416.88M | −3.1% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $12.56B | $723.41M | −$2.38M | −$66.39M | −0.5% |
| 2024 | $14.40B | $829.23M | $2.11M | −$64.74M | −0.4% |
| 2023 | $14.95B | $848.98M | −$350.10M | −$392.69M | −2.6% |
| 2022 | $13.52B | $839.98M | −$371.00M | −$416.88M | −3.1% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
YI Valuation vs Medical Distribution Median
Median of 13 stocks| Metric | YI | Medical Distribution median | vs median |
|---|---|---|---|
| P/S ratio | 0.00 | 0.36 | 0.0x the median |
| Profit margin | −0.75% | −4.03% | 3.3 pts above |
Medians across 13 Medical Distribution stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Medical Distribution Stocks
McKesson Corporation
$105.86B
CORCencora, Inc.
$63.15B
CAHCardinal Health, Inc.
$57.49B
HSICHenry Schein, Inc.
$10.01B
AHGAkso Health Group
$726.49M
FOCLEDAP TMS S.A.
$190.70M
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B